Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury.
Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury. Ann Neurol. 2014 May; 75(5):644-58.
View in:
PubMed
subject areas
Animals
Butadienes
Drug Delivery Systems
Enzyme Activation
Enzyme Inhibitors
Female
Gene Expression Regulation, Enzymologic
Gene Targeting
Group IV Phospholipases A2
Injections, Spinal
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Transgenic
Nitriles
Pilot Projects
Rats
Rats, Sprague-Dawley
Spinal Cord
Spinal Cord Injuries
authors with profiles
Joseph Vincent Bonventre, Ph.D., M.D.